Resources

This report outlines the key achievements and challenges in the last six months of the fifth year of program implementation, spanning the period April 2023 - September 2023.

This report outlines the key achievements and challenges in the first six months of the fifth year of program implementation, spanning the period October 2022 - March 2023.

This report outlines the key achievements and challenges in the last six months of the fourth year of program implementation, spanning the period April 1, 2022 - September 31, 2022.

This report outlines the key achievements and challenges in the first six months of the fourth year of program implementation, spanning the period October 1, 2021–March 31, 2022.

This report outlines the key achievements and challenges in the last six months of the third year of program implementation, spanning the period April 1, 2021–September 30, 2021.

The Global Health Science and Practice Technical Exchange (GHTechX) took place virtually from April 21 - 24, 2021. The event is curated through a partnership between USAID, the George Washington University, and the Global Health: Science and Practice Journal. Our goal is to convene speakers and technical sessions that highlight the latest and greatest in global health, with participants spanning global health experts, students, and professionals from across the global health community.

Cet évènement s’inscrit dans le cadre d’une série de webinaires de renforcement des capacités visant à améliorer les compétences nationales en matière de chaîne d’approvisionnement des programmes de MTN et à créer un espace de partage d’expérience entre pays.

This webinar is part of a series of capacity-building webinars to enhance national NTD program supply chain competences and create space for cross-country experience sharing.

Les effets indésirables (EI) particulièrement les effets indésirables graves (EIG) associés à l’administration de médicaments de masse ont un impact grave non seulement sur les personnes directement touchées, mais aussi sur la viabilité du programme national de lutte contre les maladies tropicales négligées (MTN) du ministère de la Santé.

Adverse events (AEs) particularly severe adverse events (SAEs) during and following mass drug administration have a serious effect not only on the people who are affected directly, but also on the viability of the MOH’s national NTD control program.